Molecule Name |
DB08916
|
DrugBank Groups |
Approved
|
Cluster No |
1021
|
Smiles |
ClC1(=C(F)C=CC(=C1)NC2(=NC=NC=3(C2=CC(NC(=O)C=CCN(C)C)=C(C=3)OC4(COCC4))))
|
Download |
mol2, pdbqt
|
TPSA |
88,61
|
Non-H Atoms |
34
|
Non-C/H Atoms |
10
|
Metal-Atoms |
0
|
Electronegative Atoms |
10
|
Stereo Centers |
1
|
Rotatable Bonds |
8
|
Rings Closures |
4
|
Small Rings |
4
|
Aromatic Rings |
3
|
Aromatic Atoms |
16
|
sp3-Atoms |
10
|
Symmetric atoms |
1
|
cLogS |
-5,476
|
MW |
485,946
|
cLogP |
3,6354
|
HBA |
8
|
HBD |
2
|
Ro5 violations |
0
|
Druglikeness |
-0,79682
|
DrugScore |
0,313906356536037
|
Mutagenic |
none
|
Tumorigenic |
none
|
Reproductive Effective |
none
|
Irritant |
none
|
Blood-Brain Barrier |
BBB+
|
Human Intestinal Absorption |
HIA+
|
Caco-2 Permeability |
Caco2-
|
P-glycoprotein Substrate |
Substrate
|
P-glycoprotein Inhibitor |
Inhibitor
|
P-glycoprotein Inhibitor 2 |
Inhibitor
|
Renal Organic Cation Transporter |
Non-inhibitor
|
Aqueous solubility |
-3,4735
|
Caco-2 Permeability 2 |
1,187
|
Subcellular localization |
Mitochondria
|
CYP450 2C9 Substrate |
Non-substrate
|
CYP450 2D6 Substrate |
Non-substrate
|
CYP450 3A4 Substrate |
Substrate
|
CYP450 1A2 Inhibitor |
Non-inhibitor
|
CYP450 2C9 Inhibitor |
Non-inhibitor
|
CYP450 2D6 Inhibitor |
Non-inhibitor
|
CYP450 2C19 Inhibitor |
Non-inhibitor
|
CYP450 3A4 Inhibitor |
Non-inhibitor
|
CYP Inhibitory Promiscuity |
High CYP Inhibitory Promiscuity
|
Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition 2 |
Inhibitor
|
AMES Toxicity |
Non AMES toxic
|
Carcinogens |
Non-carcinogens
|
Fish Toxicity |
High FHMT
|
Fish Toxicity (pLC50, mg/L) |
0,897
|
Tetrahymena Pyriformis Toxicity |
High TPT
|
Tetrahymena Pyriformis Toxicity (pIGC50, ug/L) |
0,6336
|
Honey Bee Toxicity |
Low HBT
|
Biodegradation |
Not ready biodegradable
|
Acute Oral Toxicity |
III
|
Rat Acute Toxicity (LD50, mol/kg) |
2,5643
|
Carcinogenicity (Three-class) |
Non-required
|